Lifecore Biomedical, Inc. De (LFCR) Income from Continuing Operations (2010 - 2025)

Lifecore Biomedical's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 1147000.0 for Q2 2025.

• In Q2 2025, Income from Continuing Operations rose 83.81% year-over-year to 1147000.0; the TTM figure through May 2025 stood at 38717000.0 (down 514.93% YoY), while the FY2025 annual figure was 38717000.0, down 514.93% from the prior year.
• Income from Continuing Operations was 1147000.0 for Q2 2025 at Lifecore Biomedical, up from 14769000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 14785000.0 in Q1 2024 to a low of 36998000.0 in Q2 2023.
• Historically, Income from Continuing Operations has averaged 6240166.67 across 5 years, with a median of 7779500.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Income from Continuing Operations slumped 971.76% in 2021, then surged 254.79% in 2023.
• A 5-year view of Income from Continuing Operations shows it stood at 7547000.0 in 2021, then tumbled by 221.92% to 9201000.0 in 2022, then soared by 254.79% to 14242000.0 in 2023, then slumped by 146.14% to 6571000.0 in 2024, then soared by 82.54% to 1147000.0 in 2025.
• The last three Income from Continuing Operations figures came in at 1147000.0 (Q2 2025), 14769000.0 (Q1 2025), and 6571000.0 (Q4 2024), per Business Quant data.